Sarcopenia Increases Death Risk In Patients Undergoing TAVI, Finds Study
- byDoctor News Daily Team
- 09 July, 2025
- 0 Comments
- 0 Mins
Korea: Sarcopenia as measured by skeletal muscle index (SMI) significantly increases 1-year mortality risk in patients who underwent transcatheter aortic valve implantation (TAVI), suggests a recent study in the American Journal of Cardiology.
There is not much data on the association between sarcopenia and clinical outcomes in patients who underwent TAVI. Yong-Hoon Yoon, Chungnam National University School of Medicine, Sejong, Republic of Korea, and colleagues evaluated a total of 522 patients with severe aortic stenosis who underwent TAVI between March 2010 and November 2018 from the prospective ASAN-TAVI registry.
SMI was calculated using routine pre-TAVI computed tomography scan. SMI was defined as skeletal muscle area at the L3 level divided by height squared. The patients were classified into the gender-specific tertile groups of SMI. The patients' mean age was 79 years and 49% were men. Mean SMI values were 41.3 ± 6.7 cm 2/m 2 in men and 34.1 ± 6.5 cm 2/m 2 in women.
Also Read: Sarcopenia, new prognostic marker in penile cancer patients: Study
Key findings of the study include:
The Kaplan–Meier estimates of all-cause mortality at 12 months were higher in the low-tertile group than in the mid- and high-tertile groups (15.5%, 7.1%, and 6.2%, respectively).
In multivariate analysis, low-tertile of SMI was an independent predictor of mortality (vs high-tertile of SMI, hazard ratio 2.69).
The all-cause mortality was substantially higher in the groups with high-surgical risk plus low SMI tertile.
The risk assessment with addition of SMI on conventional STS-PROM score was significantly improved by statistical measures of model reclassification and discrimination.
"The prognostic impact of SMI-measured sarcopenia was more prominent in patients with high surgical risks," concluded the authors.
Also Read: Aspirin after TAVI reduces bleeding vs. aspirin plus clopidogrel: POPular TAVI
The study, "Prognostic Value of Baseline Sarcopenia on 1-year Mortality in Patients Undergoing Transcatheter Aortic Valve Implantation," is published in the American Journal of Cardiology.
DOI: https://www.ajconline.org/article/S0002-9149(20)31145-0/fulltext
Disclaimer: This website is designed for healthcare professionals and serves solely for informational purposes.
The content provided should not be interpreted as medical advice, diagnosis, treatment recommendations, prescriptions, or endorsements of specific medical practices. It is not a replacement for professional medical consultation or the expertise of a licensed healthcare provider.
Given the ever-evolving nature of medical science, we strive to keep our information accurate and up to date. However, we do not guarantee the completeness or accuracy of the content.
If you come across any inconsistencies, please reach out to us at
admin@doctornewsdaily.com.
We do not support or endorse medical opinions, treatments, or recommendations that contradict the advice of qualified healthcare professionals.
By using this website, you agree to our
Terms of Use,
Privacy Policy, and
Advertisement Policy.
For further details, please review our
Full Disclaimer.
Tags:
Recent News
What Your Neck Size Says About Your Heart Health?...
- 04 November, 2025
EVOQUE TTVR Delivers Promising Real-World Results:...
- 04 November, 2025
Influenza Vaccination Reduces Mortality and Readmi...
- 04 November, 2025
Daily Newsletter
Get all the top stories from Blogs to keep track.
0 Comments
Post a comment
No comments yet. Be the first to comment!